The working team ‘EEG in Phase I of the Collegium Internationale Psychiatrae Scalarum presents a standard operating procedure (SOP) for the registration and computer-supported evaluation of pharmaco-EEG data, which is based on published guidelines. The minimum standard for recording, amplifying and filtering, validation of hardware and software, artifact treatment and fast Fourier analysis is described in a tabulated form and further explained as accompanying comments. The available SOP can be the basis for the working out of laboratory-specific SOPs. Compliance with the SOP guarantees the possibility of citation by the International Pharmaco-EEG Group (IPEG), Association for Methodology and Documentation in Psychiatry (AMDP), and Collegium Internationale Psychiatriae Scalarum (CIPS). Furthermore, an optimal standard is recommended where appropriate, which functions as a guideline.

Keywords:
Pharmacoelectroencephalography, Standard operating procedure, Guidelines, Validation, Calibration, Standardization
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.